Its anti-permeability and anti-inflammatory effects on the ‘normal’ host vasculature should theoretically limit tumor cell extravasation and vessel co-option at distant organs – in essence, allowing Ang1 to counteract some of the secondary pro-metastatic mechanisms of VEGF and Ang237, 38, 39, 40, 41. The gene discussed is VEGFA; the disease is neoplasm.